139 related articles for article (PubMed ID: 1583409)
1. Development of a therapeutic procedure for bismuth intoxication with chelating agents.
Slikkerveer A; Jong HB; Helmich RB; de Wolff FA
J Lab Clin Med; 1992 May; 119(5):529-37. PubMed ID: 1583409
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats.
Juresa D; Blanusa M; Kostial K
Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364
[TBL] [Abstract][Full Text] [Related]
3. Chelation of bismuth by combining desferrioxamine and deferiprone in rats.
Tubafard S; Fatemi SJ
Toxicol Ind Health; 2008 May; 24(4):235-40. PubMed ID: 19022876
[TBL] [Abstract][Full Text] [Related]
4. Comparison of standard chelating agents for acute mercuric chloride poisoning in mice.
Jones MM; Basinger MA; Weaver AD; Davis CM; Vaughn WK
Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):363-72. PubMed ID: 7367752
[TBL] [Abstract][Full Text] [Related]
5. 2,3-Dimercaptopropanol, 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase lead-induced inhibition of delta-aminolevulinate dehydratase in vitro and ex vivo.
Santos FW; Rocha JB; Nogueira CW
Toxicol In Vitro; 2006 Apr; 20(3):317-23. PubMed ID: 16168622
[TBL] [Abstract][Full Text] [Related]
6. 2,3-Dimercaptopropanol, 2,3-dimercaptopropane-1-sulfonic acid, and meso-2,3-dimercaptosuccinic acid inhibit delta-aminolevulinate dehydratase from human erythrocytes in vitro.
Nogueira CW; Santos FW; Soares FA; Rocha JB
Environ Res; 2004 Mar; 94(3):254-61. PubMed ID: 15016592
[TBL] [Abstract][Full Text] [Related]
7. Are 2,3-dimercapto-1-propanesulfonic acid or prussian blue beneficial in acute thallotoxicosis in rats?
Mulkey JP; Oehme FW
Vet Hum Toxicol; 2000 Dec; 42(6):325-9. PubMed ID: 11111936
[TBL] [Abstract][Full Text] [Related]
8. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
Zalups RK
J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
[TBL] [Abstract][Full Text] [Related]
9. Effect of chelating agents on biliary excretion of arsenic in perfused livers of guinea pigs pretreated with As2O3.
Reichl FX; Kreppel H; Szinicz L; Muckter H; Fichtl B; Schumann K; Forth W
Vet Hum Toxicol; 1990 Jun; 32(3):223-6. PubMed ID: 2353432
[TBL] [Abstract][Full Text] [Related]
10. Comparison of enhanced elimination of bismuth in humans after treatment with meso-2,3-dimercaptosuccinic acid and D,L-2,3-dimercaptopropane-1-sulfonic acid.
Slikkerveer A; Noach LA; Tytgat GN; Van der Voet GB; De Wolff FA
Analyst; 1998 Jan; 123(1):91-2. PubMed ID: 9581027
[TBL] [Abstract][Full Text] [Related]
11. Cadmium inhibits delta-aminolevulinate dehydratase from rat lung in vitro: interaction with chelating and antioxidant agents.
Luchese C; Zeni G; Rocha JB; Nogueira CW; Santos FW
Chem Biol Interact; 2007 Jan; 165(2):127-37. PubMed ID: 17187767
[TBL] [Abstract][Full Text] [Related]
12. Lack of effectiveness of D-penicillamine in experimental arsenic poisoning.
Kreppel H; Reichl FX; Forth W; Fichtl B
Vet Hum Toxicol; 1989 Feb; 31(1):1-5. PubMed ID: 2540587
[TBL] [Abstract][Full Text] [Related]
13. Tissue decorporation of polonium-210 in rats by DMPA.
Aposhian HV; Dart RC; Aposhian MM; Dawson BV
Res Commun Chem Pathol Pharmacol; 1987 Nov; 58(2):157-71. PubMed ID: 2827276
[TBL] [Abstract][Full Text] [Related]
14. Severe iatrogenic bismuth poisoning with bismuth iodoform paraffin paste treated with DMPS chelation.
Ovaska H; Wood DM; House I; Dargan PI; Jones AL; Murray S
Clin Toxicol (Phila); 2008 Nov; 46(9):855-7. PubMed ID: 19003595
[TBL] [Abstract][Full Text] [Related]
15. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
Flora SJ; Pande M; Kannan GM; Mehta A
Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
[TBL] [Abstract][Full Text] [Related]
16. Metal chelators and neurotoxicity: lead, mercury, and arsenic.
Bjørklund G; Mutter J; Aaseth J
Arch Toxicol; 2017 Dec; 91(12):3787-3797. PubMed ID: 29063135
[TBL] [Abstract][Full Text] [Related]
17. Role of chelating agents and antioxidants in beryllium induced toxicity.
Johri S; Shukla S; Sharma P
Indian J Exp Biol; 2002 May; 40(5):575-82. PubMed ID: 12622205
[TBL] [Abstract][Full Text] [Related]
18. The relative effectiveness of some chelating agents as antidotes in acute cadmium poisoning.
Jones MM; Weaver AD; Weller WL
Res Commun Chem Pathol Pharmacol; 1978 Dec; 22(3):581-8. PubMed ID: 216066
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of repeated parenteral administration of several chelators on the distribution and excretion of cobalt.
Llobet JM; Domingo JL; Corbella J
Res Commun Chem Pathol Pharmacol; 1988 May; 60(2):225-33. PubMed ID: 2839877
[TBL] [Abstract][Full Text] [Related]
20. Chelation in metal intoxication--Principles and paradigms.
Aaseth J; Skaug MA; Cao Y; Andersen O
J Trace Elem Med Biol; 2015; 31():260-6. PubMed ID: 25457281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
